Table 5 Biometric, lipoprotein profile distributions, assessment-insulin resistance and blood glucose distributions in relation to the PPARγ C161→T genotypes in T2DM patients

Age

58.13 ± 10.68

54.80 ± 11.05

56.50 ± 13.40

55.26 ± 12.21

Weight (kg)

66.10 ± 12.15

62.30 ± 9.06

69.38 ± 12.93

63.79 ± 10.02

Height (m)

1.65 ± 0.09

1.63 ± 0.07

1.66 ± 0.09

1.64 ± 0.07

BMI (kg/m²)

24.69 ± 4.65

23.04 ± 3.36

25.08 ± 4.67

23.62 ± 3.71

TC (mmol/L)

4.56 ± 0.89

4.42 ± 0.73

4.13 ± 0.34

4.36 ± 0.67

Trig (mmol/L)

1.93 ± 1.74

1.68 ± 1.02

1.77 ± 0.38

1.70 ± 0.92

HDL(mmol/L)

1.10 ± 0.37

1.27 ± 0.42

1.14 ± 0.27

1.25 ± 0.39

LDL (mmol/L)

2.77 ± 0.76

2.56 ± 0.70

2.49 ± 0.41

2.55 ± 0.64

apoA (g/L)

1.27 ± 0.19

1.39 ± 0.24

1.31 ± 0.13

1.36 ± 0.20

apoB (g/L)

1.14 ± 0.36

0.98 ± 0.16

1.03 ± 0.20

0.99 ± 0.18

Lp(a) (mg/L) ^Δ

1.66 ± 0.64

1.67 ± 0.46

1.24 ± 0.04

1.53 ± 0.43

FBS (mmol/L)

9.58 ± 1.80

9.92 ± 2.35

10.31 ± 0.93

10.01 ± 2.11

PPBS (mmol/L)

13.38 ± 3.43

14.05 ± 4.22

15.07 ± 2.73

14.26 ± 3.

RI ^Δ

1.84 ± 0.27

1.87 ± 0.25

1.77 ± 0.27

1.85 ± 0.25